Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
13.03 -0.04 / -0.31%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.03 0.00 / 0.00%
 
Volume: 59.6K

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 20.00, with a high estimate of 21.00 and a low estimate of 11.00. The median estimate represents a +53.49% increase from the last price of 13.03.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.40
Sales
$20.2M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.21%
 
 
 
 
 
 
Growthannually -8.93%
 
 
 
 
 
 

Sales

Growthquarterly 3.20%
 
 
 
 
 
 
Growthannually 21.60%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account